GlaxoSmithKline Pharmaceuticals Limited (BOM: 500660)
India flag India · Delayed Price · Currency is INR
2,855.35
0.00 (0.00%)
At close: Sep 11, 2024

GlaxoSmithKline Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Cash & Equivalents
-641.71349.412,8624,0521,048
Upgrade
Short-Term Investments
-9,79411,00921,7917,3209,570
Upgrade
Trading Asset Securities
-8,1325,1833,656--
Upgrade
Cash & Short-Term Investments
18,56818,56816,54128,30911,37210,618
Upgrade
Cash Growth
12.25%12.25%-41.57%148.94%7.10%-7.49%
Upgrade
Accounts Receivable
-2,2211,9242,0522,156998.01
Upgrade
Other Receivables
-1,2751,373715.31254306.15
Upgrade
Receivables
-3,4963,2972,7682,4101,304
Upgrade
Inventory
-5,2504,6005,3475,4674,830
Upgrade
Prepaid Expenses
-206.18149.6139.26146.49117.89
Upgrade
Other Current Assets
-463.33355.04517.622,631878.19
Upgrade
Total Current Assets
-27,98424,94337,08022,02617,749
Upgrade
Property, Plant & Equipment
-3,1073,1513,2543,5548,271
Upgrade
Long-Term Investments
-0.270.270.150.15-
Upgrade
Other Intangible Assets
-235.54340.91344.97433.64496.25
Upgrade
Long-Term Deferred Tax Assets
-1,4631,3351,1311,0311,105
Upgrade
Other Long-Term Assets
-2,7762,7952,6214,1013,712
Upgrade
Total Assets
-35,56633,26646,33331,14631,332
Upgrade
Accounts Payable
-6,2544,2785,7934,6613,571
Upgrade
Accrued Expenses
-1,6551,4824,6222,0661,533
Upgrade
Current Portion of Long-Term Debt
----0.241.53
Upgrade
Current Portion of Leases
-121.96120.84124.53143.53148.26
Upgrade
Current Income Taxes Payable
-2,9862,9622,9621,6371,614
Upgrade
Current Unearned Revenue
----1,800-
Upgrade
Other Current Liabilities
-4,2334,4213,4833,2383,352
Upgrade
Total Current Liabilities
-15,24913,26416,98413,54610,220
Upgrade
Long-Term Debt
-----0.24
Upgrade
Long-Term Leases
-64.6934.5576.24202.5268.37
Upgrade
Other Long-Term Liabilities
-1,6731,7611,8481,8171,792
Upgrade
Total Liabilities
-17,79015,85319,70316,36413,126
Upgrade
Common Stock
-1,6941,6941,6941,6941,694
Upgrade
Retained Earnings
-16,35115,92025,21013,34516,540
Upgrade
Comprensive Income & Other
--268.57-201.58-274.96-256.9-28.22
Upgrade
Shareholders' Equity
17,77617,77617,41326,63014,78318,206
Upgrade
Total Liabilities & Equity
-35,56633,26646,33331,14631,332
Upgrade
Total Debt
186.65186.65155.39200.77346.27418.4
Upgrade
Net Cash (Debt)
18,38218,38216,38628,10811,02610,200
Upgrade
Net Cash Growth
12.18%12.18%-41.70%154.93%8.10%-11.09%
Upgrade
Net Cash Per Share
108.49108.5196.73165.9265.0860.21
Upgrade
Filing Date Shares Outstanding
169.45169.41169.41169.41169.41169.41
Upgrade
Total Common Shares Outstanding
169.45169.41169.41169.41169.41169.41
Upgrade
Working Capital
-12,73511,67920,0968,4817,529
Upgrade
Book Value Per Share
104.93104.93102.79157.1987.26107.47
Upgrade
Tangible Book Value
17,54117,54117,07226,28514,34917,710
Upgrade
Tangible Book Value Per Share
103.54103.54100.77155.1684.70104.54
Upgrade
Land
-36.836.822.4922.49560.11
Upgrade
Buildings
-1,0991,0841,0411,0224,412
Upgrade
Machinery
-4,4894,2443,9373,9158,213
Upgrade
Construction In Progress
-139.3203.12305.02132.141,201
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.